I AM BIOCT

Rosalia Gonzales, Pfizer

I AM BIOCT

Rosalia Gonzales, Director of Compound Management and Distribution, Worldwide Research and Development, Pfizer Connecticut Laboratories, Medicinal Sciences

Visit pfizer.com

JOIN BIOCT

Be part of a diverse community of innovators committed to the growth and sustainability our bioscience community.

Join Now

CAREER CENTER

Your source for today’s talent, job opportunities and career development.

Career Center

EXCLUSIVE DISCOUNTS

New England Edge, powered by MassBio, offers you substantial savings on the products and services you use the most.

Explore Offers

SPONSORSHIPS

Boost your visibility and show your support for Connecticut’s bioscience community.

Sponsorships

We are the voice of Connecticut’s bioscience industry.

Dedicated to the growth of a vibrant bioscience ecosystem, our organization connects companies, institutions, entrepreneurs, investors, government, service providers, and other passionate, dedicated people to improve patients’ lives and public health.

Upcoming Events

ABCT Information Session

Accelerator for Biosciences in Connecticut, ABCT, is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBA’s and MD’s interested to...

2
Academic Bioscience R&D
4
Bioscience Patents
561
NIH Funding in 2018
4
Bioscience Venture Capital
8
Science & Engineering Doctorates

New !

Welcome to New England Edge – available exclusively to BioCT members.

We’ve partnered with MassBio to bring you an even-bigger purchasing program featuring the supplier discounts their members enjoy.
Save big on everything you need, from travel to office furnishings to lab supplies and more.

Take me to my exclusive discounts

GOVERNMENT ADVOCACY

Your voice in Hartford
and Washington.

BioCT keeps policy makers abreast of the latest developments and changing needs of the bioscience community, ensuring policy alignment at the state and federal level.

Read More

Newsroom

SpringWorks announces IPO

SpringWorks Therapeutics reports the pricing of its initial public offering of 9,000,000 shares of its common stock at a price to the public of $18.00...

Melinta names Sanfillipo interim CEO

Melinta Therapeutics reports that Jennifer Sanfilippo has been named interim chief executive officer and director. Prior to this appointment, Ms. Sanfilippo served as senior vice...